detected increased expression of SGLT2 mRNA in biopsies from control kidney donors and patients with nondiabetic nephropathy involving different subtypes of GN, compared to patients with diabetic nephropathy (32). This evidence concerns the gene SLC5A2 and diabetic kidney disease.